Literature DB >> 4290561

Mouse-protective properties of Bordetella pertussis serotypes in passive tests.

G Eldering, J Holwerda, J Baker.   

Abstract

In a passive protection procedure in which the ed(50) values of Bordetella pertussis antisera were determined, groups of mice were given graded intraperitoneal doses of serum, followed the next day by intracerebral challenge with 100,000 organisms. Antiserum produced with B. pertussis culture 5373, serotype 1.3, protected mice against challenge with culture 18-323, serotype 1.2.3, as effectively as did an antiserum produced with a serotype 1.2.3 culture. When two groups of mice similarly treated with pertussis immune serum were challenged with culture 353Z (serotype 1) and 18-323, respectively, much lower ed(50) values were obtained with the animals challenged with 353Z. Passive protection tests with adsorbed antiserum gave equivocal results, suggesting that some of the adsorbing antigen remained in the serum and interfered with the tests. There was no evidence that serotype is related to protection.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4290561      PMCID: PMC276688          DOI: 10.1128/jb.93.6.1758-1761.1967

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  7 in total

1.  TYPE-SPECIFIC IMMUNITY AGAINST WHOOPING-COUGH.

Authors:  N W PRESTON
Journal:  Br Med J       Date:  1963-09-21

2.  EFFECTIVENESS OF PERTUSSIS VACCINES.

Authors:  N W PRESTON
Journal:  Br Med J       Date:  1965-07-03

3.  Type-specific immunity against intracerebral pertussis infection in mice.

Authors:  N W PRESTON; P EVANS
Journal:  Nature       Date:  1963-02-02       Impact factor: 49.962

4.  Serological study of Bordetella pertussis and related species.

Authors:  G ELDERING; C HORNBECK; J BAKER
Journal:  J Bacteriol       Date:  1957-08       Impact factor: 3.490

5.  Serological studies on H. pertussis H. parapertussis and H. bronchisepticus.

Authors:  E K ANDERSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1953

6.  Potency tests for pertussis vaccines: doubtful value of intracerebral challenge test in mice.

Authors:  N W Preston
Journal:  J Pathol Bacteriol       Date:  1966-01

7.  Bordetella pertussis culture having only species factor 1.

Authors:  G Eldering; J Holwerda; J Baker
Journal:  J Bacteriol       Date:  1966-05       Impact factor: 3.490

  7 in total
  7 in total

1.  The serotypes of Bordetella pertussis isolated in Great Britain between 1941 and 1968 and a comparison with the serotypes observed in other countries over this period.

Authors:  C Bronne-Shanbury; D Miller; A F Standfast
Journal:  J Hyg (Lond)       Date:  1976-04

2.  Bordetella pertussis serotypes in the United States.

Authors:  G Eldering; J Holwerda; A Davis; J Baker
Journal:  Appl Microbiol       Date:  1969-10

Review 3.  Histamine-sensitizing factors from microbial agents, with special reference to Bordetella pertussis.

Authors:  J Munoz; R K Bergman
Journal:  Bacteriol Rev       Date:  1968-06

4.  Pertussis agglutinins in adults.

Authors:  P L Kendrick; R Y Gottshall; H D Anderson; V K Volk; W E Bunney; F H Top
Journal:  Public Health Rep       Date:  1969-01       Impact factor: 2.792

5.  The importance of agglutinin production in mice in the determination of the definitive serotype of Bordetella pertussis.

Authors:  C J Bronne-Shanbury
Journal:  J Hyg (Lond)       Date:  1976-04

6.  Antigens of Bordetella pertussis V. Separation of Agglutinogen 1 and Mouse-Protective Antigen.

Authors:  R F Ross; J Munoz
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

7.  International collaborative studies on the pertussis vaccine potency assay. Part played by the challenge in the mouse-protection test.

Authors:  R Murata; F T Perkins; M Pittman; I Scheibel; K Sladký
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.